Dentsply Sirona Inc (XRAY)
$54.11 0.20 (0.37%)
16:20 EDT XRAY Stock Quote Delayed 15 Minutes
Previous Close $54.11
Market Cap 12.31B
PE Ratio -8.11
Volume (Avg. Vol.) 984,300
Day's Range 54.08 - 54.65
52-Week Range 33.93 - 59.40
Dividend & Yield 0.35 (0.64%)
XRAY Stock Predictions, Articles, and Dentsply Sirona Inc News
- From InvestorPlace
- From the Web
Stock charts of NVDA, XRAY and TSN are set to start the new trading week on the verge of key moves.
All-American U.S. stocks like Foot Locker, Copart and Snapchat are on the mend for all the right reasons. here are the charts to watch.
The stock charts of FTNT, XRAY and AMAT are run through the technical trading wringer. Here's what you should know.
These healthcare stocks will benefit from aging baby boomers and improving financials in future quarters.
The stock charts of XRAY, PG and VLO are headed into the new year on a pretty well-defined path.
Healthcare stocks face political uncertainty. However, this mix of 7 buys offers broad diversity, and it profits from the aging of America.
Stock charts of NFLX, XRAY and UNM are dropping the most reliable technical hints as we head into a tricky trading environment.
These ten stocks are currently the most expensive stocks trading on the S&P 500 -- so buyer beware.
Portfolio Grader currently ranks Dentsply Sirona Inc (NASDAQ:XRAY) a Sell. The methodology for investing incorporated in this analytical tool developed by Louis Navellier assesses and ranks nearly 5,000 stocks each week from a fundamental and quantitative perspective. This represents no change from the previous week and is the same ranking XRAY has had from Portfolio Grader for 2 months.
These seven stocks to sell should be cleared from your portfolio as soon as possible. Here's what you need to know about each.
Navellier RatingsPowered by Portfolio Grader
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!